<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2767">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04339322</url>
  </required_header>
  <id_info>
    <org_study_id>COVID-19 in Egypt</org_study_id>
    <nct_id>NCT04339322</nct_id>
  </id_info>
  <brief_title>Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt</brief_title>
  <acronym>COVID-19</acronym>
  <official_title>Characteristics and Outcome of COVID-19 Among Egyptian Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The World Health Organization (WHO) has recently declared coronavirus disease 2019 (Covid-19)
      a public health emergency of international concern. Egypt is one of the countries that has
      been infected by Covid-19. The characteristics of clinical presentation, laboratory and
      radiological data are not yet studied. Outcomes of covid-19 in Egypt also have not been
      described yet.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients admitted to Assiut University hospital, Al Rajhi liver hospital and other covid-19
      Quarantine hospitals will be included. The characteristics of patients will be described such
      as demographic data; age, sex,history of contact to COVID-19 patients or traveling abroad and
      their clinical manifestation such as fever,cough,shortness of breath, sore throat, diarrhea.
      Laboratory data will also be included such as blood picture,D-Dimer, serum ferritin,
      creatinine, liver enzymes, oxygen saturation and covid-19 polymerase chain reaction (PCR).
      Radiological data will be described as regarding chest X-ray and/or computed tomography.

      Patients will be followed until complications, improvement, transfer to another hospital or
      death and their outcome will be described.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2020</start_date>
  <completion_date type="Anticipated">July 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Demographics of Coronavirus Disease 2019 (COVID-19) in the cohort group</measure>
    <time_frame>2 months</time_frame>
    <description>Sheet recording age, sex, co-morbidity,history of contact</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical manifestations of Coronavirus Disease 2019 (COVID-19)</measure>
    <time_frame>2 month</time_frame>
    <description>Sheet recording symptoms and signs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Laboratory data of included Coronavirus Disease 2019 (COVID-19) cohort</measure>
    <time_frame>2 months</time_frame>
    <description>blood picture,D-Dimer, creatinine, liver enzymes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radiological features of Coronavirus Disease 2019 (COVID-19) cohort</measure>
    <time_frame>2 month</time_frame>
    <description>Chest x-ray and/or Computed tomography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>outcomes of Coronavirus Disease 2019 (COVID-19) infection in the cohort group</measure>
    <time_frame>1 week</time_frame>
    <description>Data recording of the outcomes of treatment</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Characteristics Diseases</condition>
  <condition>Outcome, Fatal</condition>
  <arm_group>
    <arm_group_label>Patients with Covid-19</arm_group_label>
    <description>Patients with clinical presentation and confirmed as Covid-19 according to the definition of Egyptian Ministry of Health</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Follow up</intervention_name>
    <description>Follow up to assess the outcome until complications, improvement, death or being transferred to another quarantine hospital.</description>
    <arm_group_label>Patients with Covid-19</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with clinical presentation and confirmed as Covid-19 according to the definition
        of Egyptian Ministry of Health.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with diagnosis of Covid-19 .

        Exclusion Criteria:

          -  Patients refuse to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 7, 2020</study_first_submitted>
  <study_first_submitted_qc>April 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2020</study_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Haidi Karam</investigator_full_name>
    <investigator_title>Lecturer of Tropical Medicine and Gastroenterology</investigator_title>
  </responsible_party>
  <keyword>Covid-19</keyword>
  <keyword>characteristics</keyword>
  <keyword>Outcome</keyword>
  <keyword>Egypt</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The data prescribed in the study</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

